The race is on to develop the first daily weight-loss pill that would be both cheaper and less invasive than the current ...
OnlyFans model Lottie Moss said on her podcast that the experience was "one of the scariest things that's ever happened to me in my life." ...
Structure Therapeutics (NASDAQ:GPCR), and Terns Pharmaceuticals (NASDAQ:TERN), which are all developing oral pills as weight loss treatments, are trading higher Friday following disappointing results ...
Hedge fund Starboard Value confirmed on Monday it had filed a shareholder resolution to eliminate the dual-class share ...
Artificial heart maker Carmat on Wednesday announced the launch of a new capital increase for an initial amount of 10.3 ...
This year’s prestigious Lasker medical awards recognize a trio of scientists without whom Ozempic and other blockbuster ...
Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic—so ...
Half a century of advancements in biomedical science paved the way for today’s powerful weight-loss drugs like Ozempic — so ...
Structure Therapeutics has entered the race ... semaglutide - approved to treat Type 2 Diabetes ("T2D") under the brand name Ozempic, and Obesity under the brand name Wegovy, and Eli Lilly's ...